Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies - Concepedia

Concepedia

Publication | Open Access

Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies

DOI Full Paper Access

315

Citations

30

References

2011

Year

Mohamed L. Sorror, Brenda M. Sandmaier, Barry E. Storer, Georg‐Nikolaus Franke, Ginna G. Laport, Thomas R. Chauncey, Edward Agura, Richard T. Maziarz, Amelia Langston, Parameswaran Hari,

Abstract

Among patients aged 60 to 75 years treated with nonmyeloablative allogeneic HCT, 5-year overall and progression-free survivals were 35% and 32%, respectively.

References

	Year	Citations

Page 1